MG America, the U.S. subsidiary of MG2 of Bologna, Italy introduced the new FlexaLAB Capsule Filler. The FlexaLAB can produce up to 3,000 capsules per hour and is specifically designed for R&D laboratories, clinical trials, small batch outputs and special productions.
FlexaLAB can function at continuous or intermittent motion depending on the type of dosing unit installed. Multiple dosing units may be installed and utilized simultaneously, enabling the FlexaLAB to manufacture capsules with combinations of products—an important asset for its research-focused target audience.
The FlexaLAB can fill powders, pellets, microtablets, tablets, liquids, and certain low-dosage powder inhalants. The machine also can perform capsule-into-capsule functions.
Other features on the new FlexaLAB include a touch-screen panel with graphics and multi-language display; PLC for machine functions control; and motorized adjustment of machine speed from the monitor. Options such as a 100% weight inspector (for filled capsules) and a dry oil-free air compressor also are available.